Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

NCT06981104 ·Status: COMPLETED ·Phase: NA

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

NCT01488396 ·Status: COMPLETED ·Phase: PHASE4

NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye

NCT00739349 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

NCT02004067 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

NCT06766357 ·Status: RECRUITING ·Phase: PHASE3

Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye

NCT05131152 ·Status: UNKNOWN ·Phase: NA

A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine

NCT06329661 ·Status: COMPLETED ·Phase: PHASE4

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye

NCT06013436 ·Status: COMPLETED

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3

Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical Study

NCT04714099 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

NCT00383396 ·Status: COMPLETED ·Phase: PHASE4

Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease

NCT02229955 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy

NCT00349440 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

NCT00349583 ·Status: COMPLETED ·Phase: PHASE4

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

NCT00784719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

NCT06824844 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome

NCT05269810 ·Status: COMPLETED ·Phase: PHASE2

Tear Film Markers in Dry Eye Syndrome

NCT04515329 ·Status: WITHDRAWN ·Phase: PHASE4

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

NCT02121847 ·Status: COMPLETED ·Phase: PHASE4

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

NCT04819269 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye

NCT01558999 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

NCT00335114 ·Status: COMPLETED ·Phase: NA